BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
VEGFA
,
nitric oxide metabolic process
,
Hepatitis
,
Heart
,
Amniocentesis
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
A1 receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Response to Annexin-1 and peptide Ac2-26 of HEK293 cells expressing annexin receptor ALXR
Breast adenocarcinoma MDA-MB-231 cells treated with dexamethasone or compound A
Explore Curated Studies Results
Literature
Most Relevant Literature
An allosteric modulator of the adenosine A1 receptor potentiates the antilipolytic effect in rat adi…
Activation of the adenosine A1 receptor in the lumbosacral spinal cord improves bladder overactivity…
Adenosine A1 receptors of the medullary solitary tract arbitrate the nicotine counteraction of neuro…
The Signaling Pathways Involved in the Anticonvulsive Effects of the Adenosine A1 Receptor.
Suppression of ASIC activity by the activation of A1 adenosine receptors in rat primary sensory neur…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitaliz…
PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitaliz…
Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillat…
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and At…
A Phase 1/2, First-in-Human, Open-Label, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*0…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ